
Sek Kathiresan MD
@skathire
Followers
30K
Following
50K
Media
4K
Statuses
25K
CEO @VerveTx $VERV; Imagine if a one-time treatment led to permanent lowering of LDL cholesterol: that’s what we are developing to treat heart attack
Joined July 2012
Born in Tirupattur, India.Immigrated to Pittsburgh, PA 1980.Professor Medicine @harvardmed .CEO @VerveTx . Assimilated.
25
116
1K
Wow, say it with me:. “a functional cure” for sickle cell disease with CRISPR gene editing . All 31 patients with severe SCD, no vaso-occlusive crises (f/u 2 to 32 mos). Similar durability and efficacy for beta-thal. 👏🏽👏🏽👏🏽 .@CRISPRTX .@VertexPharma .
21
207
934
A home run!. @intelliatweets shows for first time in humans that in vivo liver gene editing (CRISPR-Cas9 mRNA + guide RNA packaged in a lipid nanoparticle). is going to work (REALLY WELL). At dose of just 0.3 mg/kg in 3 humans, .plasma TTR reductions:. 80%, 84%, & 96%. No AEs. 😳
22
168
610
News:. After 22y @MassGeneralNews @broadinstitute understanding risk & resistance to heart attack,. I am moving to new role as CEO @VerveTx - a biotech we have founded . to develop gene editing Rx that permanently reduce risk of coronary disease in adults.
100
91
600
Best news in months: . @Regeneron "its scientists have now isolated hundreds of antibodies that neutralize virus, & they’re sorting through them — as well as antibodies isolated from ppl who have recovered from COVID-19 — to find best 2 with which to create a cocktail treatment".
Regeneron's sped up its timeline for human trials of antibody therapy for #COVID19 by a couple months. Now aims to have doses for testing by early summer. George Yancopoulos: "There are always so many moving parts, but we’re hitting our best timelines"
5
141
482
Thrilled to announce that @US_FDA has cleared our. *investigational new drug (IND)* application. for VERVE-101. FDA reviewed our hold response which included:.1. interim clinical data from the ongoing heart-1 trial currently being conducted ex-U.S. 2. pre-clinical data to address
23
77
485
After being told of BRCA1 mutation, .up to 50% women opt for prophylactic mastectomy. Should this be so?. For "monogenic" forms breast ca, colorectal ca, & heart attack, we find polygenic background powerfully modifies risk. New on @medrxivpreprint .
15
204
408
Quite embarrassing for @JAMA to continue to publish these horribly confounded nutritional epidemiology studies.
In this pooled US cohort study, consumption of dietary cholesterol or eggs was associated with higher risk of incident CVD and all-cause mortality in a dose-response manner #ACC19.
16
87
367
Idea: 2016.Company: 2018.NHP data: 2020.1st patient dosed: 2022. 1st human data for in vivo liver base editing in patients with heterozygous familial hypercholesterolemia and ASCVD . 👇🏽. @American_Heart .@VerveTx .$VERV. Stay tuned!
17
44
356
@StevenSalzberg1 Wow @StevenSalzberg1. So much respect for this thoughtful response to the feedback. Simply wonderful example you are setting. 👍🏽👏🏽👌🏽.
2
12
322
Grateful to @American_Heart for this wonderful honor - the Joseph A. Vita Award. I had the opportunity to work with Dr. Vita as fellow at the Framingham Heart Study; he was a wonderful man and a terrific scientist.
Harvard scientist gets American Heart Association award for findings of inherited basis for cardiovascular disorders #AHA18.
29
34
317
Tweeps,.Thank you very much for kind words. Grateful to my family, mentors, trainees, institutions, and to this great country. From immigration 1980 with my brother (L) to .#AHA17 honor of our scientific contributions yesterday (R). A testament to power of opportunity in 🇺🇸
22
72
312
Best news of day (even better than event in DC). Preliminary study from Sahin of @BioNTech_Group . @pfizer @BioNTech_Group vaccine induced neutralizing antibody response to UK variant similar to wild-type COVID virus. 👍🏽.
8
91
299
@ashishkjha @bijans Ashish, . once we get through this wave (let's say end Feb), I do wonder if we need to change our thinking re testing. For endemic viruses (eg Flu), testing is typically done in people with symptoms (and usually just severe symptoms).
11
5
319
Having led company from my basement for the last 9 months 😳,. nice to visit our new @VerveTx offices in 500 Tech Square for first time. 👌🏽. @kendallnow
15
3
312
👇🏽 what I hope will be our most impactful discovery to date. An enzyme whose loss of function lowers blood cholesterol & *protects* against fatty liver & cirrhosis. Kudos to @connoremdin whose clever analysis of public data (@ukbiobank) led to observation.
5
121
289
Quite an awesome email to wake up to:. About $10M worth of data to be given to you for free .*and* .the data generator is asking for input on file formats. 👏🏽👏🏽 @uk_biobank - emerging as the world standard for human biology research and open data. 👇🏽
7
101
272
If you develop a once-&-done gene editing med to durably lower LDL cholesterol & Rx heart attack, what do you need?. Capital . Today, @VerveTx announces Series B fund raise of $94M led by @Wellington_Mgmt & co-led by @cascapital, with 9 new investors. 🙏.
24
17
268
Often get asked about "founding story" @VerveTx . None other than @American_Heart "One Brave Idea" competition to cure coronary heart disease. Our submission from April 2016 👇. Idea incubated with @GVteam '16-'18.Series A funding August '18. 1st patient dosing - planned 2022
12
34
270
South Asians: about 1/4 of world population. Representation in genetic studies: almost 0. 😕.
The remarkable and persistent lack of diversity in genomic studies .@NatureMedicine @SFatumo @KKuchenbaecker .@tchikowore1 @Ayub1985 @genetisaur.And a plan to fix it @LHSTM @UCL @uclbiosciences @MRC_Uganda @H3Africa @PGCgenetics @PRSdiversity @H3ABioNet
11
73
263
1st patient ever treated by CRISPR gene editing medicine: for sickle cell disease . 👏🏽👇🏽🙏🏽. @VertexPharma.@CRISPRTX. CRISPR Gene-Editing Tool: 1st Patient With Genetic Disorder Treated In U.S. : Shots - Health News : NPR
3
97
244
Amazing!. “After the CRISPR therapy, Gray’s total hemoglobin reached normal levels; of which 47% was fetal hemoglobin. It’s thought that a fetal hemoglobin level of 25%-30% is sufficient to “cure” a patient with sickle cell disease.“. New era of single, transformative therapies.
$VRTX $CRSP news! —> First CRISPR treatment for blood diseases shows early benefits in two patients via @sxbegle and me.
5
95
233
A new era of CRISPR-based medicines with single treatments that offer curative potential!. Kudos to @VertexPharma and @CRISPRTX. FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease | FDA
7
57
244
Grateful to announce👇🏽. Thanks to @GVteam (lead), @rtnarch, @FPrimeCapital, Biomatics, Partners Innovation Fund. and 2 new investors Wellington & @cascapital . Verve raises another $63m to develop gene-editing treatment for heart disease via @BostonGlobe.
29
21
240
Terrific must-read @TheLancet on COVID-19 epidemiology. Did you know: . "A simple calculation gives fraction likely to be infected without mitigation. This fraction is roughly.1–1/R0. With R0 values for COVID-19 in China around 2·5. ~60% of population would become.infected."
4
111
237
Cool new study from @Regeneron . Identification loss-of-function variants in GPR75 gene that protect against obesity. Het LoF carriers about 12lb lighter. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity
5
87
231
In @CircAHA, we publish today pre-clinical data for VERVE-101. Of note, @American_Heart tells us that for Scientific Sessions '22, this abstract the highest ranked one of all submitted from U.S. #AHA22 . Press release: Paper:
2
60
234
@ScottGottliebMD key contributor to the sentinel surveillance of COVID-19 in Seattle was the Seattle Flu Study, a collaborative effort by the Brotman Baty Institute, UW Medicine, Fred Hutch, and Seattle Children’s. cc: @JShendure head Brotman Baty.
5
36
214
@VerveTx is thrilled to announce. *Clearance* of first VERVE-101 clinical trial application (CTA) . 🎉🎉. Expect to treat 1st patient with HetFH in mid-2022. Expect clinical data in 2023. As part of planned global regulatory strategy,.CTA in UK & IND in US are up next
6
23
231
So, I grew up in Tamilnadu, a state in southern India. Imagine my delight when my father sent me (L). @VerveTx shows up in Dinamalar, largest Tamil daily paper 😀. article (L), my father's translation (R). boxed in white is "CRISPR gene editing" in Tamil!.
11
4
233
GLP-1 agonists do seem to be the *miracle* drug for the 21st century obesity epidemic:. Lose weight, lower glucose, lower triglycerides, lower BP . *AND*. Lower risk of heart attack. Oh, also, potential benefits re NASH and sleep apnea.
As @LillyPad invests heavily in a GLP-1 based pipeline for #T2D #obesity #NASH Dulaglutide annualizing at 7.3 B USD
11
47
232
We are thrilled to gain @EliLillyandCo as a new partner for @VerveTx PCSK9 & ANGPTL3 programs👇. Lilly has purchased from @BeamTx all of their previously held product rights in PCSK9 & ANGPTL3 programs for a $600M total potential deal value. For the PCSK9 & ANGPTL3 product
7
17
223